MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Specific Technologies, developer of the SpecID™ technology to rapidly detect and identify bacterial species and strain via a metabolomic fingerprint, today announced results demonstrating strain discrimination of four distinct strains of Methicillin-resistant Staphylococcus aureus (MRSA) comparable to the discrimination obtained via pulsed-field gel electrophoresis.
Help employers find you! Check out all the jobs and post your resume.
